Zusammenfassung Hintergrund und Ziele Pruritus ist eine häufige immunvermittelte unerwünschte Wirkung (irAE) unter Therapie mit Checkpoint‐Inhibitoren (ICI) und beeinträchtigt die Lebensqualität der Patienten erheblich. In dieser Studie untersuchen wir die Häufigkeit, den Schweregrad und Therapieansätze von Pruritus bei Melanompatienten unter ICI ...
Andrea Roggo +6 more
wiley +1 more source
Evaluating the potential of candidate surrogate endpoints for overall survival in treatment-naive metastatic melanoma treated with anti-PD-1-based regimens with or without anti-CTLA-4 therapy. [PDF]
Squifflet P +6 more
europepmc +1 more source
ABSTRACT Background & Aims The management of comorbidities has become increasingly relevant in unresectable hepatocellular carcinoma (uHCC) as immunotherapy prolongs survival. Atezolizumab plus bevacizumab (AB) is a standard first‐line option, but bevacizumab carries a risk of cardiovascular toxicities.
Bernardo Stefanini +55 more
wiley +1 more source
Immune Checkpoint Inhibitors and Hypothyroidism: An Emerging Public Health Challenge Identified Through a Systematic Review of ClinicalTrials.gov. [PDF]
Wu J, Wu X, Ren H.
europepmc +1 more source
ABSTRACT Adoptive cellular therapies (ACT), including tumour‐infiltrating lymphocyte (TIL), T‐cell receptor‐engineered T (TCR‐T) cell and chimeric antigen receptor T‐cell (CAR‐T) therapies, represent an evolving class of immunotherapies with established efficacy in selected haematological malignancies and emerging applications in solid tumours ...
Sarah Childs +15 more
wiley +1 more source
Durable benefits, but no improvements in overall survival: what can we learn from CheckMate 238 after 9 years of follow-up? [PDF]
Lopes CDH, Spreafico A, Araujo DV.
europepmc +1 more source
Beyond PD-L1 and HER2: emerging predictive biomarkers in gastroesophageal tumors. [PDF]
Alsina M +2 more
europepmc +1 more source
Immune Checkpoint Inhibitor-Induced Vogt-Koyanagi-Harada-like Disease Complicated by Inflammatory Macular Neovascularisation: A Case Report and Literature Review. [PDF]
Papavasileiou ME +5 more
europepmc +1 more source
Dual versus single-agent immune checkpoint inhibitor therapy in microsatellite instability-high metastatic colorectal cancer: an analysis based on reconstructed patient data. [PDF]
Zaidi A +5 more
europepmc +1 more source
Immunotherapy Rechallenge in HCC: A Second Chance for Response? [PDF]
Da Fonseca LG +2 more
europepmc +1 more source

